ResVita Bio

📍 Berkeley, United States🗓 Founded 2021👥 6 employees💰 Last funded May 2022
Biotechnology🌐 resvitabio.com
Website LinkedIn
The physical and emotional challenges of chronic skin diseases are devastating to patients, particularly children. ResVita Bio seeks to restore and maintain the vitality of the skin through engineered skin probiotics. Through synthetic biology and metabolic engineering, we are developing a safe and versatile skin microbial platform that continuously deliver therapies that address the causes of chronic skin diseases. ResVita Bio is developing a rich product pipeline to treat inflammatory skin diseases like Netherton Syndrome, atopic dermatitis, psoriasis, acne, and rosacea.
1
Total investors
1
Early stage
0
Mid stage
0
Late stage
2021
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in ResVita Bio?
ResVita Bio has 1 investors on record on gritt.io, including 1 early-stage backers.
When did ResVita Bio last raise funding?
The most recent investment in ResVita Bio recorded on gritt.io was in May 2022.
When was ResVita Bio founded?
ResVita Bio was founded in 2021.
What industry is ResVita Bio in?
ResVita Bio operates in Biotechnology. Find similar Biotechnology investors on gritt.io.
Where is ResVita Bio based?
ResVita Bio is headquartered in Berkeley, United States.